Form 4: Adagio Medical Holdings Director Acquires 90,000 Stock Options

Keyvan Mirsaeedi-Farahani, a director at Adagio Medical Holdings, acquired 90,000 non-qualified stock options on March 20, 2025, according to a Form 4 filing.

Summary

• Keyvan Mirsaeedi-Farahani, a director of Adagio Medical Holdings, Inc. (ADGM), filed a Form 4 indicating a change in beneficial ownership.
• On March 20, 2025, Mirsaeedi-Farahani acquired 90,000 non-qualified stock options with an exercise price of $0.865.
• These options were granted under the Issuer's 2024 Equity Incentive Plan and approved by the Compensation Committee on March 20, 2025.
• The options vest monthly over a three-year period, starting July 31, 2024, with 1/36th of the shares vesting each month of continuous service.
• The options expire on July 31, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating confidence in the company's future. The sentiment is neutral to positive.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company over a three-year period.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common practice in the medical device industry to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the medical device industry, similar to companies like Medtronic, Boston Scientific, and Abbott.
• Vesting schedules of three years are also standard practice to ensure long-term alignment with company goals.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning management's interests with theirs.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, stock options, Adagio Medical Holdings, beneficial ownership, director, equity incentive plan, ADGM